Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Successful Scale Up of a High Yielding Viral Vector Suspension Platform to 500 L John Ketz, at Andelyn Biosciences, Denis Kole, at Pall Corporation and Benben Song, at Pall Corporation As gene therapies move toward commercialization, the journey to manufacture a high-quality product while achieving economies of scale and reducing fac... July 12, 2022 2:00pm Single Use Process for Production of AAV Gene Therapy Products Lance Marquardt at PTC Therapeutics, Vikas Gupta, at Repligen, Rachel Legmann at Repligen, and Gilbert Huang at Repligen An overview of single use manufacturing for the production of AAV gene therapy products with comparisons to traditional monoclonal antibody production... 1 month ago | 120 mins Material Requirements to Support Gene Therapy Development Clare Blue, Director of Analytical Development at Biogen and James Wilkinson, VP of Sales and Customer Success at Refeyn Manufacturing processes for gene therapy products are generally low yielding compared to production processes for other biologics. The material requir... 1 month ago | 73 mins Enabling Scalable & Cost-Effective Point of Care for Cell & Gene Therapies Qasim Rafiq, Xavier de Mollerat du Jeu, Sean Chang The transformative potential to change the way human disease is treated using cell and gene therapy has motivated rapid technological advancements tow... 12 months ago | 62 mins Analytical Challenges for Gene Therapy Clare Blue at Biogen and Saba Hussein at Vironova Presented by Clare Blue and Dr Saba Hussein One of the biggest challenges for AAV gene therapy products is establishing an appropriate analytical str... 2 years ago | 74 mins Scalable AAV Manufacturing: Addressing Challenges Across the Workflow Chao Yan Liu, Gino Stolfa, Monica Commerford Thermo Fisher Scientific product experts discuss upstream and downstream solutions across the entire workflow. In this webinar, you'll learn about sc... 12 months ago | 85 mins FDA Perspective on Aseptic Process Simulation for Cell Therapy Product Manufa... Dr Lily Koo, Consumer Safety Officer at FDA and Dr Keen Chung, Principal Scientist (Upstream Process) at Pall Biotech FDA Perspective on Aseptic Process Simulation for Cell Therapy Product Manufacturing Presented by Dr Lily Koo, Consumer Safety Officer at Food and Dr... 3 years ago | 83 mins Qualification of Raw Materials Used in the Manufacturing of Cellular Therapies Jim Richardson, Sr Scientific Liaison at USP and Horst Ruppach, Ph.D. Scientific Director at Charles River Presented by Jim Richardson, Sr Scientific Liaison at United States Pharmacopeia Dr. Richardson works in the standards pipeline development group wit... 2 years ago | 79 mins FDA Perspective on Aseptic Process Simulation for Cell Therapy Product Manufa... Dr Lily Koo, Consumer Safety Officer at FDA and Dr Keen Chung, Principal Scientist (Upstream Process) at Pall Biotech FDA Perspective on Aseptic Process Simulation for Cell Therapy Product Manufacturing Presented by Dr Lily Koo, Consumer Safety Officer at Food and Dru... 2 years ago | 82 mins Qualification of Raw Materials Used in the Manufacturing of Cellular Therapies Jim Richardson, Sr Scientific Liaison at USP and Horst Ruppach, Ph.D. Scientific Director at Charles River Presented by Jim Richardson, Sr Scientific Liaison at United States Pharmacopeia Dr. Richardson works in the standards pipeline development group wit... 3 years ago | 80 mins
